2023 - Research.com Genetics in Denmark Leader Award
Finn Cilius Nielsen spends much of his time researching Genetics, Cell biology, Internal medicine, Molecular biology and Single-nucleotide polymorphism. The study incorporates disciplines such as 5-HT5A receptor, Receptor, Biochemistry, Insulin-like growth factor 2 and Fusion protein in addition to Cell biology. His Internal medicine research includes elements of Endocrinology, Real-time polymerase chain reaction and Oncology.
His Molecular biology study combines topics from a wide range of disciplines, such as Growth factor, Messenger RNA, Gene expression and Cathepsin G. His Messenger RNA research incorporates elements of RNA and Protein biosynthesis. Finn Cilius Nielsen has included themes like Genome and Allele, Haplotype in his Single-nucleotide polymorphism study.
His scientific interests lie mostly in Internal medicine, Genetics, Molecular biology, Gene and Cell biology. The Internal medicine study combines topics in areas such as Gastroenterology, Endocrinology, Oncology and Genotype. His Oncology research incorporates themes from Breast cancer and Ovarian cancer.
His Molecular biology research focuses on Messenger RNA and how it connects with RNA, Protein biosynthesis and Ribonucleoprotein. His study on Cell biology is mostly dedicated to connecting different topics, such as Cell growth. In Gene expression, he works on issues like Pathology, which are connected to microRNA.
Finn Cilius Nielsen mostly deals with Internal medicine, Oncology, Gene, Breast cancer and Genetics. His biological study spans a wide range of topics, including Transcriptome, Biopsy, Hazard ratio, Prospective cohort study and Single-nucleotide polymorphism. His research investigates the connection between Gene and topics such as Cancer research that intersect with problems in microRNA, Homologous recombination, Normal oral mucosa, Plasma samples and Real-time polymerase chain reaction.
Finn Cilius Nielsen interconnects Tumor heterogeneity, Mutation, FANCM, Prostate cancer and Risk factor in the investigation of issues within Breast cancer. His work on Genome-wide association study, Genotyping, Genetic testing and DNA repair as part of general Genetics research is frequently linked to Dicentric chromosome, thereby connecting diverse disciplines of science. Finn Cilius Nielsen works mostly in the field of Genotyping, limiting it down to topics relating to Medical genetics and, in certain cases, Germline mutation, Mutation and Gene mutation, as a part of the same area of interest.
His primary scientific interests are in Internal medicine, Oncology, Breast cancer, Gene and Cancer research. His Oncology research includes themes of Exome sequencing, Confidence interval, Biopsy, Colorectal cancer and Genomic Profile. His Breast cancer research is multidisciplinary, incorporating perspectives in Transcriptome, Prostate cancer and Risk factor.
His Gene study frequently links to related topics such as Computational biology. Finn Cilius Nielsen combines subjects such as Real-time polymerase chain reaction, Biomarker, microRNA, Formalin fixed paraffin embedded and Cancer biomarkers with his study of Cancer research. His Cancer research is included under the broader classification of Genetics.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
MicroRNA-10a Binds the 5′UTR of Ribosomal Protein mRNAs and Enhances Their Translation
Ulf Andersson Ørom;Finn Cilius Nielsen;Anders H. Lund.
Molecular Cell (2008)
Ancient human genome sequence of an extinct Palaeo-Eskimo
Morten Rasmussen;Yingrui Li;Stinus Lindgreen;Jakob Skou Pedersen.
A Family of Insulin-Like Growth Factor II mRNA-Binding Proteins Represses Translation in Late Development
Jacob Nielsen;Jan Christiansen;Jens Lykke-Andersen;Anders H. Johnsen.
Molecular and Cellular Biology (1999)
Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).
Nasim Mavaddat;Daniel Barrowdale;Irene L. Andrulis;Susan M. Domchek.
Cancer Epidemiology, Biomarkers & Prevention (2012)
p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC.
N R Christoffersen;R Shalgi;L B Frankel;E Leucci.
Cell Death & Differentiation (2010)
A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population
Antonis C. Antoniou;Xianshu Wang;Zachary S. Fredericksen;Lesley McGuffog.
Nature Genetics (2010)
RNA‐binding IMPs promote cell adhesion and invadopodia formation
Jonas Vikesaa;Thomas V O Hansen;Lars Jønson;Rehannah Borup.
The EMBO Journal (2006)
TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis
Adam P. Gregory;Calliope A. Dendrou;Kathrine E. Attfield;Aiden Haghikia;Aiden Haghikia.
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk
Fergus J. Couch;Xianshu Wang;Lesley McGuffog;Andrew Lee.
PLOS Genetics (2013)
Ascertainment Biases in SNP Chips Affect Measures of Population Divergence
Anders Albrechtsen;Finn Cilius Nielsen;Rasmus Nielsen.
Molecular Biology and Evolution (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: